Kiniksa Pharmaceuticals L... (KNSA)
undefined
undefined%
At close: undefined
20.20
-0.30%
After-hours Dec 13, 2024, 04:00 PM EST

Kiniksa Pharmaceuticals Ltd. Forcast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for KNSA stock have an median target of 35, with a low estimate of 34 and a high estimate of 40. The median target predicts an increase of 72.75% from the current stock price of 20.26.

Analyst Consensus: Buy
Target Low Average Median High
Price $34 $36.6 $35 $40
Change 67.82% 80.65% 72.75% 97.43%

AI Analyst Report

According to 5 stock analyst, the rating for Kiniksa Pharmaceuticals Ltd. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Apr 24May 24Jul 24Sep 24Oct 24Nov 24
Strong Buy 000000
Buy 121111
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 2 1 1 1 1

Financial Forecast this Year

Revenue This Year
421.17M
from 270.26M
Increased by 55.8%
Revenue Next Year
573.60M
from 421.17M
Increased by 36.2%
EPS This Year
-0.15
from 0.2
Increased by 25.0%
EPS Next Year
0.6
from -0.15
Increased by -300%